ERC Advanced Grant for Rene Bernards to study senescence therapy for cancer


Molecular oncologist Rene Bernards of the Netherlands Cancer Institute has been awarded an ERC Advanced Grant to conduct research into  senescence therapy for cancer as a strategy to overcome drug resistance.

The European Research Council Advanced Grant is allocated annually to established, leading principal investigators who want long-term funding to pursue a ground-breaking, high-risk project. Advanced Grants may be awarded up to € 2.5 million for a period of 5 years.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.